PEGS Europe—Protein and Antibody Engineering Summit
November 9–13, 2020
Meet Genedata experts at PEGS Europe.
Don't miss the opportunity to see how Genedata solutions efficiently support the whole biopharmaceutical R&D workflow, including screening and protein engineering, expression and purification, characterization and analysis of protein therapeutics, cell line design and development, bioprocess optimization, stratification of clinical trial subjects, and quality control of biologicals.
To get more information about Genedata solutions, please contact info(at)genedata.com.
Recommended Oral Presentations
Synthetic DNA Technologies Enable Fast and Responsive SARS- CoV-2 Antibody Discovery and Optimization
Aaron K. Sato, Ph.D., Chief Scientific Officer, Biopharma, Twist Bioscience
Engineering Bispecific Antibodies
Thursday, November 12 | 3:20 pm–3:50 pm
Utilizing its proprietary DNA technology to write synthetic libraries, Twist Biopharma provides antibody discovery and optimization solutions for the biotechnology industry, based on a strategy of combining highly diverse synthetic naïve antibody phage display libraries with an end-to-end digitalization workflow that allows us to identify leads against difficult-to-drug targets in high-throughput. Here, we present a panel of high affinity anti-SARS-CoV-2 S1 and anti-ACE2 antibodies we have identified that may have both therapeutic and/or diagnostic applications.